Siemens Healthineers AG (XTER:SHL) Long-Term Capital Lease Obligation : €513 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Long-Term Capital Lease Obligation?

Siemens Healthineers AG's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was €513 Mil.

Siemens Healthineers AG's quarterly Long-Term Capital Lease Obligation stayed the same from Mar. 2024 (€0 Mil) to Jun. 2024 (€0 Mil) but then increased from Jun. 2024 (€0 Mil) to Sep. 2024 (€513 Mil).

Siemens Healthineers AG's annual Long-Term Capital Lease Obligation declined from Sep. 2022 (€446 Mil) to Sep. 2023 (€426 Mil) but then increased from Sep. 2023 (€426 Mil) to Sep. 2024 (€513 Mil).

Siemens Healthineers AG Long-Term Capital Lease Obligation Historical Data

The historical data trend for Siemens Healthineers AG's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Long-Term Capital Lease Obligation Chart

Siemens Healthineers AG Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

265.00

438.00

446.00

426.00

513.00

Siemens Healthineers AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															426.00	-	-	-	513.00

Siemens Healthineers AG (XTER:SHL) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Siemens Healthineers AG Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Siemens Healthineers AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (XTER:SHL) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SEMHF:USA SMMNY:USA 1SHL:Italy SHLd:UK 0PMJ:UK SHL:Austria

Address

Siemensstr. 3, Forchheim, BY, DEU, 91301

Website

https://www.siemens-healthineers.com

Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.

Executives

Dr. Nathalie Von Siemens	Supervisory Board
Darleen Caron	Board of Directors
Dr. Jochen Schmitz	Board of Directors
Prof. Dr. Ralf Peter Thomas	Supervisory Board
Dr. Christoph Zindel	Board of Directors
Dr. Andreas Christian Hoffmann	Supervisory Board
Peer M. Schatz	Supervisory Board
Dr. Bernhard Montag	Board of Directors

Siemens Healthineers AG Headlines

No Headlines